Procedure for patients with thinking and memory problems could help medics decide which drugs are most suitable
Researchers have developed a blood test for patients with thinking and memory problems to check if they have Alzheimer’s and to see how far it has progressed.
The team behind the work say the test could help medics decide which drugs would be most suitable for patients. For example, new drugs such as donanemab and lecanemab can help slow the progression of Alzheimer’s, but only in people in the early stages of the disease.
About Author
More Stories
Newborns treated with antibiotics respond less well to vaccines, study shows
As a geneticist, I will not mourn 23andMe and its jumble of useless health information | Adam Rutherford
Bonobos may combine words in ways previously thought unique to humans